Upgrades
Maxim Group upgraded the previous rating for TOP Ships Inc TOPS from Hold to Buy. NoneThe stock has a 52-week-high of $32.80 and a 52-week-low of $0.75. At the end of the last trading period, TOP Ships closed at $0.78.
According to Needham, the prior rating for BioCryst Pharmaceuticals Inc BCRX was changed from Hold to Buy. BioCryst Pharmaceuticals earned $0.38 in the fourth quarter, compared to $0.40 in the year-ago quarter. The stock has a 52-week-high of $19.30 and a 52-week-low of $7.61. At the end of the last trading period, BioCryst Pharmaceuticals closed at $8.64.
For Masimo Corp MASI, Raymond James upgraded the previous rating of Market Perform to Outperform. Masimo earned $1.00 in the third quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of $176.42 and a 52-week-low of $108.89. At the end of the last trading period, Masimo closed at $160.89.
According to Wolfe Research, the prior rating for Merck & Co Inc MRK was changed from Peer Perform to Outperform. Merck & Co earned $1.62 in the fourth quarter, compared to $1.80 in the year-ago quarter. At the moment, the stock has a 52-week-high of $115.49 and a 52-week-low of $72.88. Merck & Co closed at $109.07 at the end of the last trading period.
For Shopify Inc SHOP, DA Davidson upgraded the previous rating of Neutral to Buy. For the fourth quarter, Shopify had an EPS of $0.07, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $780.00 and a 52-week-low of $23.63. Shopify closed at $41.42 at the end of the last trading period.
For Alcoa Corp AA, Citigroup upgraded the previous rating of Neutral to Buy. Alcoa earned $0.70 in the fourth quarter, compared to $2.50 in the year-ago quarter. The stock has a 52-week-high of $98.09 and a 52-week-low of $33.55. At the end of the last trading period, Alcoa closed at $48.07.
Keybanc upgraded the previous rating for Nordson Corp NDSN from Sector Weight to Overweight. In the first quarter, Nordson showed an EPS of $1.95, compared to $2.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $251.26 and a 52-week-low of $194.89. Nordson closed at $211.91 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
Vertical Research downgraded the previous rating for Huntsman Corp HUN from Buy to Hold. In the fourth quarter, Huntsman showed an EPS of $0.04, compared to $0.95 from the year-ago quarter. The current stock performance of Huntsman shows a 52-week-high of $41.65 and a 52-week-low of $23.54. Moreover, at the end of the last trading period, the closing price was at $28.84.
According to Oppenheimer, the prior rating for Biomarin Pharmaceutical Inc BMRN was changed from Outperform to Perform. Biomarin Pharmaceutical earned $0.04 in the third quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $117.77 and a 52-week-low of $70.73. At the end of the last trading period, Biomarin Pharmaceutical closed at $105.97.
For The Hackett Group Inc HCKT, Craig-Hallum downgraded the previous rating of Buy to Hold. The Hackett Group earned $0.36 in the fourth quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $24.78 and a 52-week-low of $16.92. At the end of the last trading period, The Hackett Group closed at $21.25.
For Constellation Energy Corp CEG, Credit Suisse downgraded the previous rating of Outperform to Neutral. At the moment, the stock has a 52-week-high of $97.89 and a 52-week-low of $42.18. Constellation Energy closed at $80.37 at the end of the last trading period.
According to BTIG, the prior rating for LGI Homes Inc LGIH was changed from Neutral to Sell. LGI Homes earned $1.45 in the fourth quarter, compared to $4.53 in the year-ago quarter. The stock has a 52-week-high of $134.05 and a 52-week-low of $71.73. At the end of the last trading period, LGI Homes closed at $104.66.
According to Northcoast Research, the prior rating for Texas Roadhouse Inc TXRH was changed from Buy to Neutral. In the fourth quarter, Texas Roadhouse showed an EPS of $0.89, compared to $0.76 from the year-ago quarter. The current stock performance of Texas Roadhouse shows a 52-week-high of $107.31 and a 52-week-low of $68.58. Moreover, at the end of the last trading period, the closing price was at $104.58.
Rosenblatt downgraded the previous rating for Sirius XM Holdings Inc SIRI from Buy to Neutral. For the fourth quarter, Sirius XM Holdings had an EPS of $0.09, compared to year-ago quarter EPS of $0.08. The current stock performance of Sirius XM Holdings shows a 52-week-high of $6.85 and a 52-week-low of $4.45. Moreover, at the end of the last trading period, the closing price was at $4.45.
For ACM Research Inc ACMR, Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. For the third quarter, ACM Research had an EPS of $0.42, compared to year-ago quarter EPS of $0.19. The current stock performance of ACM Research shows a 52-week-high of $83.79 and a 52-week-low of $5.46. Moreover, at the end of the last trading period, the closing price was at $12.11.
Truist Securities downgraded the previous rating for Interface Inc TILE from Buy to Hold. For the third quarter, Interface had an EPS of $0.30, compared to year-ago quarter EPS of $0.29. The stock has a 52-week-high of $15.05 and a 52-week-low of $8.90. At the end of the last trading period, Interface closed at $11.14.
Evercore ISI Group downgraded the previous rating for Occidental Petroleum Corp OXY from In-Line to Underperform. For the third quarter, Occidental Petroleum had an EPS of $2.44, compared to year-ago quarter EPS of $0.87. The current stock performance of Occidental Petroleum shows a 52-week-high of $77.13 and a 52-week-low of $37.55. Moreover, at the end of the last trading period, the closing price was at $59.82.
For Industrias Bachoco SAB de CV IBA, JP Morgan downgraded the previous rating of Overweight to Neutral. In the fourth quarter, Industrias Bachoco SAB showed an EPS of $0.08, compared to $0.63 from the year-ago quarter. The current stock performance of Industrias Bachoco SAB shows a 52-week-high of $54.24 and a 52-week-low of $36.98. Moreover, at the end of the last trading period, the closing price was at $53.21.
For ZipRecruiter Inc ZIP, Raymond James downgraded the previous rating of Strong Buy to Outperform. In the fourth quarter, ZipRecruiter showed an EPS of $0.17, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $25.00 and a 52-week-low of $13.78. At the end of the last trading period, ZipRecruiter closed at $23.25.
For AbbVie Inc ABBV, Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the fourth quarter, AbbVie showed an EPS of $3.60, compared to $3.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $175.91 and a 52-week-low of $134.09. AbbVie closed at $152.00 at the end of the last trading period.
According to Piper Sandler, the prior rating for Horizon Bancorp (IN) HBNC was changed from Overweight to Neutral. Horizon Bancorp earned $0.48 in the fourth quarter, compared to $0.54 in the year-ago quarter. The stock has a 52-week-high of $20.78 and a 52-week-low of $14.45. At the end of the last trading period, Horizon Bancorp closed at $15.63.
According to Atlantic Equities, the prior rating for American International Group Inc AIG was changed from Overweight to Neutral. For the fourth quarter, American Intl Gr had an EPS of $1.36, compared to year-ago quarter EPS of $1.58. The stock has a 52-week-high of $65.73 and a 52-week-low of $47.05. At the end of the last trading period, American Intl Gr closed at $59.72.
See all analyst ratings downgrades.
Initiations
With a Buy rating, Lake Street initiated coverage on NeuroPace Inc NPCE. The price target seems to have been set at $10.00 for NeuroPace. In the third quarter, NeuroPace showed an EPS of $0.48, compared to $0.34 from the year-ago quarter. The current stock performance of NeuroPace shows a 52-week-high of $9.54 and a 52-week-low of $1.22. Moreover, at the end of the last trading period, the closing price was at $5.34.
Piper Sandler initiated coverage on NewtekOne Inc NEWT with a Neutral rating. In the third quarter, NewtekOne showed an EPS of $0.62, compared to $0.56 from the year-ago quarter. The stock has a 52-week-high of $28.42 and a 52-week-low of $14.75. At the end of the last trading period, NewtekOne closed at $19.83.
With a Buy rating, Roth MKM initiated coverage on Immix Biopharma Inc IMMX. The price target seems to have been set at $14.00 for Immix Biopharma. At the moment, the stock has a 52-week-high of $3.90 and a 52-week-low of $0.68. Immix Biopharma closed at $2.07 at the end of the last trading period.
For Ryvyl Inc RVYL, HC Wainwright & Co. initiated coverage, by setting the current rating at Neutral. For the third quarter, Ryvyl had an EPS of $0.00, compared to year-ago quarter EPS of $0.04. The stock has a 52-week-high of $1.01 and a 52-week-low of $0.40. At the end of the last trading period, Ryvyl closed at $0.49.
With an Outperform rating, Credit Suisse initiated coverage on Olema Pharmaceuticals inc OLMA. The price target seems to have been set at $12.00 for Olema Pharmaceuticals. Olema Pharmaceuticals earned $0.57 in the third quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $6.08 and a 52-week-low of $2.00. At the end of the last trading period, Olema Pharmaceuticals closed at $4.16.
With an Outperform rating, Cowen & Co. initiated coverage on OmniAb Inc OABI. The price target seems to have been set at $10.00 for OmniAb. At the moment, the stock has a 52-week-high of $5.13 and a 52-week-low of $1.91. OmniAb closed at $3.86 at the end of the last trading period.
DA Davidson initiated coverage on Manhattan Associates Inc MANH with a Neutral rating. The price target for Manhattan Associates is set to $145.00. In the fourth quarter, Manhattan Associates showed an EPS of $0.81, compared to $0.48 from the year-ago quarter. The current stock performance of Manhattan Associates shows a 52-week-high of $158.61 and a 52-week-low of $106.02. Moreover, at the end of the last trading period, the closing price was at $143.04.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.